Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Some drugs used to treat inflammation may cause hair loss.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Laser hair removal works well for people with dark hair and light skin, but it's less effective for light hair or dark skin; improvements are expected.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Cilostazol helps hair grow by making hair root cells grow faster and changing growth factor levels.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Targeting EGFR may help reduce hair loss from chemotherapy.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Proper education can prevent traction alopecia in women of color.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Higher fiber intake may reduce psoriasis severity, but more research is needed for effective dietary strategies.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Personalized treatment plans are important for people with alopecia areata.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Researchers developed a nanomedicine for acne treatment that delivers medication with less irritation and is non-irritating for oily skin.

Animal models are crucial for learning about hair loss and finding treatments.